Sign up for Table of Contents Alerts.
Email this page
Print this page
Review
Colorectal Cancer: New Advances in Immunotherapy
Rafael Cubas, Min Li, Changyi Chen and Qizhi Yao
volume 6 | issue 1
January 2007Pages: 11 - 17
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Colorectal cancer remains the second leading cause of cancer-related mortality in the United States. Although surgical resection is still the primary treatment for colorectal cancer, in recent years, there has been a remarkable progress in the development of new therapies to treat colorectal cancer. Response rates have increased substantially and new immunotherapeutic approaches are shedding new light in the battle against the disease. This review will focus on the current immunotherapeutic approaches being developed and will discuss clinical data for some of these new treatments.
Authors
Rafael Cubas
Baylor College of Medicine, Houston, Texas
Min Li
Baylor College of Medicine, Houston, Texas
Changyi Chen
Baylor College of Medicine, Houston, Texas
Qizhi Yao
Baylor College of Medicine, Houston, Texas
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.